With Antonis Sakellarios, University Hospital of Patras, Rio-Patras - Greece and Evangelos Andreakos, Academy of Athens Biomedical Research Foundation, Athens - Greece.

In this episode, Antonis Sakellarios speaks with Evangelos Andreakos, exploring the growing scientific and clinical evidence that cardiovascular disease (CVD) and depression are deeply intertwined, not isolated conditions. The conversation underlines why treating these conditions in isolation may limit patient outcomes and introduces innovative approaches, such as integrated risk stratification tools that support both cardiovascular and mental health care.

With Antonis Sakellarios, University Hospital of Patras, Rio-Patras - Greece and Evangelos Andreakos, Academy of Athens Biomedical Research Foundation, Athens - Greece.

In this episode, Antonis Sakellarios speaks with Evangelos Andreakos, presenting the key outputs and breakthroughs of the TO_AITION project and highlighting how research on cardiovascular disease (CVD) and depression comorbidities is being translated into practical tools and strategies.

The conversation emphasises the development of innovative platforms for identifying individuals at risk of both CVD and depression, as well as collaborative disease network analyses and experimental models that reveal shared biological pathways linking the heart and brain.

Antonis Sakellarios and Evangelos Andreakos also underscore how these findings support evidence-based, holistic approaches to patient care, demonstratinga how integrated, multidisciplinary strategies can improve long-term health.

In this episode of EHRA PATHS, we are joined by Hein Heidbuchel and Michiel Rienstra, together with Emma Svennberg, leading experts in atrial fibrillation and cardiovascular research.

Together, we examine the rationale behind a novel clinical trial testing software designed to tackle comorbidities in AF.

The conversation highlights the logistical and scientific challenges of trial design and reflects on how evidence from digital solutions can be integrated into guideline-based care.

With Jessica van Setten, UMC Utrecht, Folkert Asselbergs, Amsterdam University Medical Centre, and Pim van der Harst, UMC Utrecht, The Netherlands.

In this episode of NextGen and AI4HF, we are joined by Professors Pim van der Harst and Folkert Asselbergs - two leading cardiologists driving digital transformation in cardiovascular care. Together, we explore how cutting-edge technologies are reshaping the cardiology landscape, from automating workflows to enabling personalised, federated care. We discuss issued of trust, real-world implementation and challenges, data diversity, and what it takes to bring innovation from research settings into everyday clinical practice.

This podcast

In this episode of Cardio Talk Latest Research, Machteld Boonstra from Amsterdam University Medical Centre interviews Dr. Kazem Rahimi, Professor of Cardiovascular Medicine and Population Health at the University of Oxford, about how leveraging existing large-scale population health data from registries and biobanks offers a valuable approach to training and validating AI models for the early detection of congestive heart failure (CHF) deterioration.

With Machteld Boonstra, Amsterdam University Medical Centre, and Folkert Asselbergs, Amsterdam University Medical Centre - The Netherlands.

Machteld Boonstra and Folkert Asselbergs discuss how artificial intelligence can be trustworthy in clinical practice, which is the aim of the AI4HF project.

This podcast was recorded in September 2024.

With Isabelle van Gelder, Michiel Rienstra and Michelle Lobeek, University Medical Centre Groningen - The Netherlands, and Prash Sanders, University of Adelaide - Australia.

In this episode of Cardio Talk Latest Research, Isabelle van Gelder interviews Michiel Rienstra, Michelle Lobeek and Prash Sanders about the EHRA-PATHS clinical trial, which focuses on improving the quality of life for patients with atrial fibrillation and comorbidities. They discuss the clinical trial's design, methodology, and implementation in detail.

This podcast was recorded in April 2024.